AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 81.1% in June

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 22,100 shares, an increase of 81.1% from the June 15th total of 12,200 shares. Based on an average daily volume of 1,800 shares, the days-to-cover ratio is presently 12.3 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in AstraZeneca stock. Kennedy Capital Management LLC acquired a new position in AstraZeneca PLC (OTCMKTS:AZNCF) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 37,554 shares of the company’s stock, valued at approximately $5,068,000. Hedge funds and other institutional investors own 40.87% of the company’s stock.

AstraZeneca Trading Down 0.3 %

Shares of OTCMKTS:AZNCF traded down $0.45 on Friday, hitting $153.41. The company had a trading volume of 606 shares, compared to its average volume of 3,262. AstraZeneca has a 1 year low of $118.16 and a 1 year high of $162.00. The firm’s 50-day simple moving average is $155.35 and its two-hundred day simple moving average is $141.26.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.